No clean published consensus was available, so the comparison is chiefly against NHC’s prior-year baseline. The filing shows a stronger operating quarter, but the market read should focus on recurring earnings rather than the large GAAP jump, which was affected by investment gains and other adjustments. GAAP net income attributable to NHC rose 70.0% to $40.3 million, but the company’s more comprehensive adjusted figure rose only 7.2% to $27.6 million (Non-GAAP reconciliation). That makes this a solid operating improvement, not a transformational earnings beat.
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Net operating revenues | $408.0 million | $374.9 million | +8.8% (Financial Highlights) |
| Income from operations | $48.9 million | $34.1 million | +43.5% (Income Statement) |
| Operating margin | 12.0% | 9.1% | +2.9 percentage points (Income Statement) |
| Adjusted net income | $27.6 million | $25.7 million | +7.2% (Non-GAAP reconciliation) |
| Adjusted diluted EPS | $1.74 | $1.65 | +5.5% (Non-GAAP reconciliation) |
| Total skilled-nursing patient days | 749,723 | 729,519 | +2.8% (Skilled Nursing Patient Days) |
| Average skilled-nursing per diem | $366.88 | $361.42 | +1.5% (Skilled Nursing Per Diems) |
| Dividend declared per share | $0.67 | $0.64 | +4.7% (Financial Highlights) |
The biggest positive is margin expansion, not revenue growth alone. Revenue increased 8.8%, helped primarily by the June 1 acquisition of five facilities with 639 licensed beds (Press Release). Income from operations grew much faster, lifting the operating margin from 9.1% to 12.0% (Income Statement). Patient days grew 2.8% while the average per diem rose 1.5%, suggesting both added capacity and better reimbursement or payer mix contributed; the improvement was not purely an accounting gain (Skilled Nursing Per Diems; Skilled Nursing Patient Days).
The acquisition makes the headline growth less organic and limits how much of the improvement can be extrapolated. NHC explicitly attributes the revenue increase primarily to the five-facility acquisition (Press Release). The filing does not provide same-facility results, acquisition contribution, or forward guidance, so it is unclear how much of the 12.0% operating margin reflects the acquired facilities versus better performance across the legacy portfolio.
The balance sheet strengthened even as cash declined. NHC reported no current or long-term debt at June 30, 2026 versus $40.0 million at December 31, 2025, while property and equipment increased to $726.8 million from $673.8 million (Balance Sheet Data). Cash, cash equivalents, and marketable securities fell to $210.2 million from $255.8 million, consistent with acquisition or investment spending, but the debt elimination reduces financial leverage (Balance Sheet Data).
Net read: operationally better, but not an unambiguous earnings surprise. The filing delivers meaningful margin improvement, higher volume, a modest dividend increase, and a debt-free balance sheet. Against that, normalized diluted EPS advanced only 5.5%, the revenue gain was acquisition-led, and no outlook was raised because none was provided (Non-GAAP reconciliation; Press Release). With no substantiated consensus to establish a precise beat or miss, the result reads as mildly favorable on operations but mixed overall versus what investors may already have assumed.
Read the original 8-K on SEC EDGAR ↗